Emily Jones

Publications

632

Citations

H-Index

2020

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hôpital Saint-Antoine

King's College London

Servier (France)

Sorbonne Université

Emily Jones is an author at The University of Texas MD Anderson Cancer Center specializing in cellular therapies, cell transplantation, and hematology.

Top concepts

MedicineHematologyImmunologyCell TherapyImmunotherapyCell TransplantationOncologyAutoimmunityHealthCell Biology

Publications per year

2020–2022

Publications

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +9

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

Francesco Paolo Tambaro, Harjeet Singh, Emily Jones et al. · Leukemia · 2021 · 167 citations · Full text

Hematological Malignancy, Cell Therapy, Medicine +11

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 121 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +10

Rows per page

1–3 of 3